| Completed | 4 | 224 | RoW | Lopinavir/ritonavir plus Emtricitabine/Tenofovir versus Efavirenz plus Emtricitabine/Tenofovir, Lopinavir/ritonavir Aluvia (ALUABT), Efavirenz Stocrin (EFVBMM), Emtricitabine/Tenofovir Truvada (TRUGLD) | University of California, San Francisco, National Institutes of Health (NIH), Gilead Sciences, Abbott, Merck Sharp & Dohme LLC | Kaposi's Sarcoma, HIV Infections | 02/12 | 07/12 | | |
